Capnocytophaga cynodegmi (formerly "DF-2 like organism"), a commensal organism of the canine oral cavity, is a capnophilic, gram-negative, facultative bacillus. C. cynodegmi has rarely been encountered in human diseases. We report the first known case of cellulitis, bacteremia, and pneumonitis caused by C. cynodegmi in a diabetic man from central India following a dog bite.
cynodegmi and was differentiated from Capnocytophaga canimorsus by its ability to ferment sucrose, raffinose, xylose, and inulin and by its growth at 72°C. The isolate had gliding mobility, showed beta-hemolysis on blood agar with 5% rabbit blood, was positive for catalase, oxidase, arginine dihydrolase, O-nitrophenyl-␤-D-galactopyranoside, and esculin, and produced acid from cellobiose, dextrin, fructose, D-glucose, glycogen, lactose, maltose, D-mannose, melibiose, D-galactose, starch, and raffinose. The isolate did not grow on MacConkey agar or triple sugar iron agar, was negative for indole, urease, lysine and ornithine decarboxylase, Simmon's citrate, nitrate, and gelatin, and did not produce gas from D-glucose or acid from D-mannitol or D-xylose. The antimicrobial susceptibility of our isolate was determined by the Kirby-Bauer disk diffusion method in chocolate agar supplemented with 5% sheep blood following incubation for 96 h at 37°C. The organism was susceptible to penicillin G, amoxicillin, chloramphenicol, norfloxacin, ciprofloxacin, ofloxacin, gentamicin, amikacin, kanamycin, netromycin, cephalexin, cefazolin, cefuroxime, cefotaxime, cefoperazone, ceftazidime, ceftriaxone, clindamycin, erythromycin, and vancomycin (5-g disk; zone diameters, Ͼ16 mm) and resistant to tetracycline, doxycycline, colistin, and trimethoprim-sulfamethoxazole (zone diameters, Ͻ10 mm) and did not exhibit intermediate susceptibility (zone diameters, 10 to 16 mm) to any of the antibiotics tested. Pseudomonas aeruginosa and Staphylococcus aureus that were susceptible to the administered antibiotics were coisolated from the pus culture. Defervescence occurred on the seventh hospital day. Subsequent blood and pus cultures and chest radiographs remained noncontributory. Therapy was continued for 12 days. Three months later at follow-up, the patient was well on oral antidiabetic therapy.
Capnocytophaga spp. (Centers for Disease Control dysgonic fermenter 1 and 2 [DF-1 and DF-2]) are fastidious, capnophilic, facultatively anaerobic, gram-negative, filamentous rods with tapered ends and gliding mobility (2, 8, 10) . The ecologic niche of the DF-2 group is the canine oral cavity (2, 8, 10) . Over 150 DF-2 strains were reclassified on the basis of genetic relatedness and phenotypic characteristics as DF-2 (C. canimorsus) and DF-2-like (C. cynodegmi) organisms (2). C. cani-morsus can cause a wide spectrum of diseases, ranging from mild to fulminant (2, 3, 6, 8, 10, 11) , and is frequently recovered from human blood, localized wounds following dog bites, other clinical specimens of immunocompromised patients, and occasionally in immunocompetent hosts (2, 3, 6, (8) (9) (10) (11) . Until now, only one report appeared in the English literature from the United States of a C. cynodegmi human wound infection (five strains) and post-corneal transplant endophthalmitis (one strain), with no evidence of systemic infection or immunocompromisation after dog bites or cat scratches (2) . C. cynodegmi has not been previously recovered from a diabetic patient or in India (3, 13) .
Most of the human isolates of C. canimorsus and C. cynodegmi from infected dog bite wounds occur as a part of aerobic and anaerobic polymicrobial flora (2, 3, 5, 7, 8, 10-12, 14) , which may overshadow their clinical significance. In our patient, P. aeruginosa and S. aureus were isolated concurrently with C. cynodegmi from tissue fluid but were considered nonsystemic pathogens, as they were not grown in serial blood cultures.
Both C. canimorsus and C. cynodegmi attach to, are phagocytosed by, and multiply intracellularly in mouse macrophage cells (4) . While C. canimorsus produces an exotoxin with cytotoxic effects within 48 h, C. cynodegmi has no such effects (4) .
C. canimorsus is susceptible to penicillin, quinolones, clindamycin, and cephalosporins, as demonstrated by disk diffusion, agar dilution, and antimicrobial gradient strip-testing methods (1-3, 5-8, 11, 12) . A significant number of C. canimorsus isolates demonstrate beta-lactamase activity (1, 5, 6, 8, 10, 11) ; variable trimethoprim-sulfamethoxazole, aminoglycoside, and metronidazole sensitivity (1, 5) ; and uniform resistance to aztreonam (1) . Our data suggest that the drug susceptibility pattern of C. cynodegmi is similar to that of C. canimorsus (1-3, 5-8, 10, 12, 14) , and penicillin can be considered the drug of choice for treatment of C. cynodegmi.
